CDMOs announced expansions, exhibitors showcased automated equipment, and supply chain strategy discussions were a focus at CPHI Milan 2026.
|Articles|September 2, 2022
- Pharmaceutical Technology, September 2022
- Volume 46
- Issue 9
- Pages: 12
Barrier Integrated Vial Fill/Finish System
Author(s)Pharmaceutical Technology Editors
Cellefill is a vial fill/finish system that designed to promote flexibility via an integrated barrier solutions.
Cellefill, from Flexicon Liquid Filling, part of Watson-Marlow Fluid Technology Solutions, is a turnkey, vial fill/finish system that is designed to promote flexibility via an integrated barrier solution. It comes in three models with different barrier technologies that are designed to suit various filing requirements and class cleanrooms, each of which features peristaltic pump performance, an integrated barrier, and environmental monitoring.
The technology uses Flexicon’s FPC60 aseptic vial filling machine and barrier technologies from Franz Ziel GmbH to enable end-to-end aseptic manufacturing of advanced therapy medicinal products. It also has aseptic single-use systems, pre-sterilized ready-to-use product containers, and a no-touch transfer debagging system.
Articles in this issue
about 4 years ago
Pfizer’s Idea Orchardabout 4 years ago
Exploring Options for Optimizing Cell Line Developmentabout 4 years ago
Reducing Blind Spots in the Pharma Supply Chainabout 4 years ago
Delivery Kinetics for Topical Drugsabout 4 years ago
Delivering a Difference in Formulationabout 4 years ago
A Harmonized Approach to Performing a Risk-Based Audit Trail Reviewabout 4 years ago
Advances in Environmental Monitoringabout 4 years ago
Robust Bioanalytical Studies Can Aid in Regulatory SubmissionsRelated to this article
Mitigating nitrosamine risk requires assessing each product individually and chasing zero nitrite in pharmaceutical excipients is often impractical and costly.
Clinical, manufacturing, safety, and commercial teams all lean on shared data. They need to agree on who publishes each data product, who can use it, and what evidence goes with it.
Continuous overall equipment effectiveness can be used to pinpoint hidden downtime and process bottlenecks in real time.
The PharmTech team focused on its coverage of AAPS PharmSci 360 this week, conducting interviews with experts on a range of topics including formulation platforms, AI, amorphous solid dispersions, and animal studies.
The agreement between CDER and OII with allow for coordinated marketing application assessments and inspections.
Shubhajit Paul, a senior research fellow in Boehringer Ingelheim’s Department of Material Analytical Sciences, spoke with PharmTech at AAPS PharmSci 360 to explain how tabletability prediction can be improved for roller-compacted formulations.
This week on PharmTech.com, experts discussed E&L suitability standards, rare disease treatment development, sourcing ingredient suppliers, the use of AI in quality control, and more.
Trending on Pharmaceutical Technology
1
FDA’s New Inspection Playbook Counts Remote Assessments and MRA Reports Toward Facility Evaluations
2
Late-Phase Impurities Need Reference Standards: AAPS PharmSci 360 2026
3
Improving Oral Peptide Delivery Through Structural Modifications
4
Using OEE Monitoring to Justify Expenditure on Aging Production Lines
5